Ebola virus disease
Ebola

Ebola is the common name of the Ebola virus disease.

Ebola virus disease has fatality rates ranging from 50-90%.

Death from Ebola virus disease is commonly due to multiple organ failure and hypovolemic shock.

Mékambo in Gabon is the site of several outbreaks of Ebola virus disease.

Ebola Virus Disease begins with a sudden onset of an influenza-like stage characterized by general malaise, fever with chills, arthralgia, myalgia, and chest pain.

MVD is a viral hemorrhagic fever (VHF), and the clinical symptoms are indistinguishable from Ebola virus disease (EVD).

Ebola virus disease (EVD) or Ebola hemorrhagic fever (EHF) is the human disease which may be caused by any of four of the five known ebola viruses.

TAFV is one of four ebolaviruses that causes Ebola virus disease (EVD) in humans (in the literature also often referred to as Ebola hemorrhagic fever, EHF).

Contrary to Ebola virus disease (EVD), which has been associated with heavy rains after long periods of dry weather, triggering factors for spillover of marburgviruses into the human population have not yet been described.

In another recent study, Dr. Joseph B. McCormick of the Federal Centers for Disease Control tested specimens kept from an outbreak of Ebola virus disease in a rural area of Zaire in 1976.

In July 2012, an outbreak of Ebola virus disease was reported in Kagadi, and as of 14 August 2012, had infected 24 and killed 16, a 66% case fatality rate, bringing back memories of the 2000 Uganda Ebola outbreak.

The name Ebola virus is derived from the Ebola River (a river that was at first thought to be in close proximity to the area in Zaire where the first recorded Ebola virus disease outbreak occurred) and the taxonomic suffix virus.

EVD due to TAFV infection cannot be differentiated from EVD caused by other ebolaviruses by clinical observation alone, which is why the clinical presentation and pathology of infections by all ebolaviruses is presented together on a separate page (see Ebola virus disease).